DBC, In re, 545 F.3d 1373, 2008 U.S. App. LEXIS 24713 (Fed. Cir. 2008)   03 Nov. 2008
MAJOR ISSUES:  Reexamination; Substantial New Question of Patentability.
The Federal Circuit’s DBC decision addresses the “substantial new question of patentability” standard for PTO reexamination of a patent. For discussion of this issue, see Chisum Patent Law Digest § 3413.20; Chisum on [...]

Advanced Software Design Corp. v. Federal Reserve Bank of St. Louis, 583 F.3d 1371, 2009 U.S. App. LEXIS 21464 (Fed. Cir. 2009) (NEWMAN, Prost & Moore) advancedsoftware09302009    30 Sept. 2009
MAJOR ISSUES: United States Government–Use for the Government with its “Authorization or Consent.”
A patent concerned a method for detecing fraudulent bank checks.  uspatno6792110  A district court lacked [...]

Advanced Software Design Corp. v. Federal Reserve Bank of St. Louis, — F.3d —-, 2009 U.S. App. LEXIS 21464 (Fed. Cir. 2009) (NEWMAN, Prost & Moore) … CPLRG0002

DBC, In re, 545 F.3d 1373, 2008 U.S. App. LEXIS 24713 (Fed. Cir. 2008) … CPLRG0001

03 Nov. 2008; DBC, In re, 545 F.3d 1373, 2008 U.S. App. LEXIS 24713 (Fed. Cir. 2008) … CPLRG0001

30 Sept. 2009; Advanced Software Design Corp. v. Federal Reserve Bank of St. Louis, — F.3d —-, 2009 U.S. App. LEXIS 21464 (Fed. Cir. 2009) (NEWMAN, Prost & Moore) … CPLRG0002

Board of Trustees of The Leland Stanford Junior University v. Roche Molecular Systems, Inc., 583 F.3d at 832, 2009 U.S. App. LEXIS 21465 (Fed. Cir. 2009) (LINN, Prost & Moore) stanfordroche093020091   30 Sept. 2009
MAJOR ISSUES:  Standing–Ownership Counterclaim by Accused Infringer–State Statute of Limitations
Assignment Agreement–Assignment of Present Interest in Future Inventions–Equitable Title–Earlier Agreement to Assign Right [...]

Board of Trustees of The Leland Stanford Junior University v. Roche Molecular Systems, Inc., — F.3d at —-, 2009 U.S. App. LEXIS 21465 (Fed. Cir. 2009) (LINN, Prost & Moore) … CPLRG0003

30 Sept. 2009; Board of Trustees of The Leland Stanford Junior University v. Roche Molecular Systems, Inc., — F.3d at —-, 2009 U.S. App. LEXIS 21465 (Fed. Cir. 2009) (LINN, Prost & Moore) … CPLRG0003

Janssen Pharmaceutica N.V. v. Teva Pharmaceuticals USA, Inc., 583 F.3d 1317, 2009 U.S. App. LEXIS 21166 (Fed. Cir. 2009) (DYK & Mayer; GAJARSA, dissenting) janssenteva09252009  25 Sept. 2009
MAJOR ISSUES: Utility–Enablement–Method of Treating Disease
A patent claimed a method of treating Alzheimer’s disease by administering the compound galanthamine.  uspatno4663318  A district court correctly held the patent invalid for lack [...]